2seventy bio, Inc. (NASDAQ:TSVT) Receives Consensus Rating of “Moderate Buy” from Analysts

2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) has been given an average rating of “Moderate Buy” by the nine research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, four have given a buy rating and one […]

Leave a Reply

Your email address will not be published.

Previous post Analyzing Gevo (NASDAQ:GEVO) and Golden Arrow Merger (NASDAQ:GAMC)
Next post BRP Inc. (NASDAQ:DOOO) Receives $97.00 Average Price Target from Analysts